Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia
Authors
Keywords
-
Journal
VASCULAR MEDICINE
Volume 20, Issue 3, Pages 237-244
Publisher
SAGE Publications
Online
2015-04-03
DOI
10.1177/1358863x15574321
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential Vascular Mechanisms of Ramipril Induced Increases in Walking Ability in Patients With Intermittent Claudication
- (2014) Anna A. Ahimastos et al. CIRCULATION RESEARCH
- Quality of care among patients undergoing lower extremity revascularization
- (2014) David P Slovut et al. VASCULAR MEDICINE
- Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
- (2014) Ehrin J. Armstrong et al. Journal of the American Heart Association
- Effect of Ramipril on Walking Times and Quality of Life Among Patients With Peripheral Artery Disease and Intermittent Claudication
- (2013) Anna A. Ahimastos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Statin Medications and Mortality, Major Adverse Cardiovascular Event, and Amputation-Free Survival in Patients With Critical Limb Ischemia
- (2013) Gregory G. Westin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia
- (2013) Jayer Chung et al. JOURNAL OF VASCULAR SURGERY
- Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
- (2013) F Gerald R Fowkes et al. LANCET
- The global pandemic of peripheral artery disease
- (2013) Alan T Hirsch et al. LANCET
- Gender-related variation in the clinical presentation and outcomes of critical limb ischemia
- (2013) Caroline E McCoach et al. VASCULAR MEDICINE
- Secondary Prevention and Mortality in Peripheral Artery Disease
- (2011) Reena L. Pande et al. CIRCULATION
- ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 Performance Measures for Adults With Peripheral Artery Disease
- (2010) Jeffrey W. Olin et al. CIRCULATION
- Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United States
- (2010) Elizabeth M. Mahoney et al.
- Endothelial Dysfunction
- (2009) Paul M. Vanhoutte CIRCULATION JOURNAL
- Critical limb ischemia
- (2009) Vinit N. Varu et al. JOURNAL OF VASCULAR SURGERY
- Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry
- (2008) Patrice P. Cacoub et al. ATHEROSCLEROSIS
- Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis
- (2008) Gianpaolo Reboldi et al. JOURNAL OF HYPERTENSION
- Long-Term Prognosis of Patients With Peripheral Arterial Disease
- (2008) Gijs M.J.M. Welten et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Role of Bradykinin, Nitric Oxide, and Angiotensin II Type 2 Receptor in Imidapril-Induced Angiogenesis
- (2007) Ping Li et al. HYPERTENSION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started